Follow-The-Filings

Security · featured owners

INDV Indivior Pharmaceuticals Inc.

Health Care COMMON STOCK Equity as of 2026 Q2 among managers we track

  • 1 Owner
  • Max 3.5%
  • $251M
  • 1 reduce 1 exit

Who owns this now

Largest portfolio weights among featured holders · max 3.5% (Howard Marks - Oaktree Capital Management) · not free-float ownership

  1. Howard Marks reduce 3.5%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Howard Marks - Oaktree Capital Management 2026 Q2 3.5% Reduce −12.3% 6,127,212 $251M history
Michael Krensavage - Krensavage Asset Management exited 2026 Q2 last 2026 Q1 4.1% Exit −4.05% 339,532 $10M history

1 current · 1 exited last period · options excluded

SEC filings

Recent issuer filings from EDGAR · 15 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
424B3 Filing Doc
8-K 1.01,7.01,9.01 Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
10-Q Filing Doc
8-K 5.02,5.07 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
10-Q Filing Doc
DEFA14A Filing Doc
8-K 1.01,1.02,2.03,3.02,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
10-K Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 14 rows shown

Filed Form Detail Links
4 Period Aug 27, 2026 Filing Doc
4 Period Aug 5, 2026 Filing Doc
4 Period Jul 10, 2026 Filing Doc
4 Period Jun 22, 2026 Filing Doc
4 Period Jun 11, 2026 Filing Doc
4 Period Jun 8, 2026 Filing Doc
4 Period May 13, 2026 · 6 forms Filing Doc
4 Period May 12, 2026 Filing Doc
4 Period Mar 14, 2026 Filing Doc
4 Period Mar 13, 2026 Filing Doc
4 Period Mar 9, 2026 Filing Doc
4 Period Mar 6, 2026 Filing Doc
4 Period Mar 3, 2026 · 4 forms Filing Doc
4 Period Feb 9, 2026 · 4 forms Filing Doc

Updated 1 day ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2024 FY2025
Revenue $1.19B $1.24B
Gross profit $957M $994M
Gross margin * 80.6% 80.2%
Net income $2M $210M
Net margin * 0.2% 16.9%

Balance sheet

Metric FY2024 FY2025
Total current assets $839M $652M
Total non-current assets * $480M $549M
Total assets $1.32B $1.2B
Total current liabilities $939M $914M
Total non-current liabilities * $729M $386M
Total equity -$348M -$98M

Cash flow

Metric FY2024 FY2025
Cash from operations $36M -$27M
Cash from investing $69M -$66M
Cash from financing -$102M -$30M
Net change in cash * $3M -$123M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders